Literature DB >> 25858894

Low frequency of mutations in Chinese with acute myeloid leukemia: Different disease or different aetiology?

Jiawei Yin1, Xiaoli Xie1, Fan Zhang1, Zheng Chen1, Chenxi Hu1, Guangsong Su1, Hong Liu2, Yanwen Zheng1, Chao He1, Hongjie Shen2, Qiaocheng Qiu2, Jun He2, Zhirong Pan3, Robert Peter Gale4, Depei Wu2, Bin Yin5.   

Abstract

Mutations in FLT3, DNMT3A, NRAS, NF1 and TP53 occur in persons of predominately European descent with acute myeloid leukemia (AML). Some, such as internal tandem duplication of FLT3 (FLT3-ITD) and point mutations in DNMT3A and NRAS, are especially frequent whereas others such as NF1 and TP53 are less so. Frequencies of these mutations in persons with seemingly similar AML from other genetic groups are largely unknown. We studied 269 Chinese (mostly Han) with de novo AML. FLT3-ITD was detected in 51 subjects (23%; 95% CI, 17-28%), R882 mutation of DNMT3A in 17 (6%; 95% CI, 3-9%) and NRAS mutation in 17 (7%; 95% CI, 3-9%). No mutations in NF1 and only 1 mutation in TP53 (1%, 95% CI, <2.5%) were detected. Except for FLT3-ITD, frequencies of these mutations are significantly less than those in persons of predominately European descent with AML. The reason(s) for this disparity is unknown but may offer clues to the aetiology of AML in different populations or may indicate some mutations associated with AML in persons of predominately European descent are not fundamental to the aetiology of the disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Chinese; Ethnicity; Mutation

Mesh:

Substances:

Year:  2015        PMID: 25858894     DOI: 10.1016/j.leukres.2015.03.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database.

Authors:  Yuqian Sun; Eric Beohou; Myriam Labopin; Liisa Volin; Noel Milpied; Ibrahim Yakoub-Agha; Simona Piemontese; Emmanuelle Polge; Mohamed Houhou; Xiao-Jun Huang; Mohamad Mohty; Arnon Nagler; Norbert-Claude Gorin
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

2.  Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

Authors:  Xiao-Qing Yuan; Dao-Yu Zhang; Han Yan; Yong-Long Yang; Ke-Wei Zhu; Yan-Hong Chen; Xi Li; Ji-Ye Yin; Xiao-Lin Li; Hui Zeng; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.